Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.

Bindraban, Anita N

Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs. [electronic resource] - International journal of clinical pharmacy Oct 2018 - 1372-1379 p. digital

Publication Type: Journal Article; Validation Study

2210-7711

10.1007/s11096-018-0692-y doi


Aged
Aged, 80 and over
Decision Support Systems, Clinical
Drug-Related Side Effects and Adverse Reactions--epidemiology
Electrocardiography
Female
Humans
Logistic Models
Long QT Syndrome--chemically induced
Male
Middle Aged
Models, Statistical
Netherlands
ROC Curve
Retrospective Studies
Risk Factors
Sensitivity and Specificity